The ROE as of November 2024 (TTM) for EyePoint Pharmaceuticals, Inc. (EYPT) is -43.01%

According to EyePoint Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.01%. This represents a change of 291.54% compared to the average of -10.98% of the last 4 quarters.

EyePoint Pharmaceuticals, Inc. (EYPT) Historical ROE (quarterly & annually)

How has EYPT ROE performed in the past?

The mean historical ROE of EyePoint Pharmaceuticals, Inc. over the last ten years is -198.94%. The current -43.01% ROE has changed -78.38% with respect to the historical average. Over the past ten years (40 quarters), EYPT's ROE was at its highest in in the December 2016 quarter at -0.45%. The ROE was at its lowest in in the June 2020 quarter at -309.22%.

EyePoint Pharmaceuticals, Inc. (EYPT) ROE by Quarter and Year

Discovering the peaks and valleys of EyePoint Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

EyePoint Pharmaceuticals, Inc. (EYPT) Average ROE

How has EYPT ROE performed in the past?

The current ROE of EyePoint Pharmaceuticals, Inc. (EYPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

EyePoint Pharmaceuticals, Inc. (EYPT) ROE vs. Peers

How is EYPT’s ROE compared to its peers?

EyePoint Pharmaceuticals, Inc.’s ROE is greater than Ocuphire Pharma, Inc. (-30.19%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Protalix BioTherapeutics, Inc. (-30.89%), greater than SELLAS Life Sciences Group, Inc. (-629.45%), greater than Alpha Tau Medical Ltd. (-38.62%), greater than HCW Biologics Inc. (-2516.87%), greater than Innate Pharma S.A. (-84.39%), greater than Orchestra BioMed Holdings, Inc. (-107.04%), greater than Chimerix, Inc. (-50.78%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Mereo BioPharma Group plc (-69.11%), greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than ALX Oncology Holdings Inc. (-93.02%), greater than Cabaletta Bio, Inc. (-50.10%), greater than Viracta Therapeutics, Inc. (-680.30%), greater than Biomea Fusion, Inc. (-118.90%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than HOOKIPA Pharma Inc. (-49.25%),

Build a custom stock screener for EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EyePoint Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EyePoint Pharmaceuticals, Inc. (EYPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EyePoint Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.